share_log

啓明醫療-B：獨立非執行董事逝世及繼續暫停買賣

VENUS MEDTECH-B: PASSING AWAY OF AN INDEPENDENT NON-EXECUTIVE DIRECTOR AND CONTINUED SUSPENSION OF TRADING

香港交易所 ·  Feb 7 09:51
Summary by Moomoo AI
啟明醫療-B（股份代號：2500）宣布，公司獨立非執行董事劉允怡先生於2024年2月7日逝世。劉先生自2019年7月起擔任獨立非執行董事，並在董事會提名委員會、薪酬與考核委員會及審計委員會中擔任重要角色。董事會對劉先生的逝世表示哀悼，並對其家屬致以慰問。劉先生逝世後，公司董事會組成不符合香港聯合交易所有限公司證券上市規則的多項要求，包括獨立非執行董事的最低人數及比例，以及審計委員會和提名委員會的成員要求。公司將尋找合適人選填補空缺，以符合上市規則。此外，公司股份自2023年11月23日起已暫停買賣，並將繼續暫停直至符合復牌條件。
啟明醫療-B（股份代號：2500）宣布，公司獨立非執行董事劉允怡先生於2024年2月7日逝世。劉先生自2019年7月起擔任獨立非執行董事，並在董事會提名委員會、薪酬與考核委員會及審計委員會中擔任重要角色。董事會對劉先生的逝世表示哀悼，並對其家屬致以慰問。劉先生逝世後，公司董事會組成不符合香港聯合交易所有限公司證券上市規則的多項要求，包括獨立非執行董事的最低人數及比例，以及審計委員會和提名委員會的成員要求。公司將尋找合適人選填補空缺，以符合上市規則。此外，公司股份自2023年11月23日起已暫停買賣，並將繼續暫停直至符合復牌條件。
Kai Ming Medical -B (stock code: 2500) announces that Mr. Liu Yunyi, an independent non-executive director of the company, died on 7 February 2024. Mr. Liu has served as an Independent Non-Executive Director since July 2019 and has held important roles on the Nominating Committee of the Board, the Remuneration and Assessment Committee and the Audit Committee. The Board of Directors mourned the death of Mr. Liu and offered condolences to his family. Following Mr. Liu's death, the Company's Board of Directors constituted a number of requirements that did not comply with the Listing Rules of the Stock Exchange of HKEx Limited, including the minimum number and proportion of independent non-executive directors, and the membership requirements of the Audit Committee and Nomination Committees. The Company will search for the right person to fill vacancies to comply with listing rules. In addition, the company's shares have been suspended from 23 November 2023 and will continue to be suspended until the conditions for the duplication are met.
Kai Ming Medical -B (stock code: 2500) announces that Mr. Liu Yunyi, an independent non-executive director of the company, died on 7 February 2024. Mr. Liu has served as an Independent Non-Executive Director since July 2019 and has held important roles on the Nominating Committee of the Board, the Remuneration and Assessment Committee and the Audit Committee. The Board of Directors mourned the death of Mr. Liu and offered condolences to his family. Following Mr. Liu's death, the Company's Board of Directors constituted a number of requirements that did not comply with the Listing Rules of the Stock Exchange of HKEx Limited, including the minimum number and proportion of independent non-executive directors, and the membership requirements of the Audit Committee and Nomination Committees. The Company will search for the right person to fill vacancies to comply with listing rules. In addition, the company's shares have been suspended from 23 November 2023 and will continue to be suspended until the conditions for the duplication are met.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more